AMRUTAJAN HEALTH LTD

Sells over-the-counter consumer healthcare products in India, with four reporting segments. OTC Products is the core franchise, contributing 65.3% of FY26 segment revenue at Rs 328.32 crore, built around pain-relief brands including Back Pain Roll On and Head Roll On, which grew 12% and 21% respectively. Women's Hygiene & Personal Care accounts for 27.8% (Rs 139.91 crore), led by the Comfy XL variant which grew 44%. Beverages make up 6.3% (Rs 31.56 crore) and Others 0.6%. Only OTC Products is profitable at the segment level (EBIT Rs 83.44 crore), while Women's Hygiene, Beverages and Others each reported negative EBIT in FY26. Distribution was expanded during the year — stockist network up 9%, outlet coverage up 12%, and 44,000 new chemist outlets added, with a stated target of 100,000 chemist outlets by September 2027. New product launches included razors, antiseptic plaster, ortho pain oil and a nasal spray. The cost base is dominated by other operating expenses at 23.6% of revenue and materials at 21.2%, with employees at 12.7% and depreciation at 1.3%; capex was 10.9% of revenue.